MarketInOut Stock Screener Log In | Sign Up
 

VivoSim Labs Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
VivoSim Labs Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2.46 mln
Float13.83 mln
Earnings Date11/06/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

31.07
Highly suspicious

Relative Strength

15 / 100
Significantly lagging

Pre-Tax Margin

-11,012%
Severely loss-making

ROE

-351
Deeply negative

Altman Z-Score

-140
Deeply distressed

Business Description

VivoSim Labs Inc. is a San Diego-based company, founded in 2007, that helps pharmaceutical and biotechnology firms test drugs using lab-built three-dimensional human tissue models of the liver and intestine. These models closely replicate the structure and behavior of real human tissue, allowing clients to better understand how drugs affect the body and predict potential side effects before clinical trials. The company offers both standard screening services and custom research projects, supporting drug developers at every stage of the development process.

Key Fundamentals

EPS-4.47
ROE-351
RPS0.03
ROIC-463
ROA-154
Interest Cover-944
EBITDA, mln-12.13
EV / EBITDA-0.36
EV / EBIT-0.35
Revenue, mln0.11
EV / Revenue38.69

Quote Details

Last 0.1485
Change -0.0109 (-6.84%)
Open 0.1535
Volume 744,622
Turnover 110,576
Average Volume 803,191

Financial Ratios

Pre-Tax Profit Margin-11,012
Current Ratio1.70
Price / Sales5.42

Financial Strength

Altman Z-Score-140
Piotroski F-Score 3 / 9
Beneish M-Score31.07
Short Ratio0.78
Short % of Float4.27

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.35% 16 / 100   
1 Month -34.12% 10 / 100   
2 Months -70.59% 4 / 100   
6 Months -89.83% 2 / 100   
1 Year -93.52% 4 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog